Amesite Inc. Announces $3.6 Million Public Offering to Fuel AI-Driven Solutions

2 Sources

Share

Amesite Inc., a technology company specializing in AI-driven solutions, has priced its public offering at $3.00 per share, aiming to raise approximately $3.6 million for general corporate purposes and expansion of its AI-powered products.

News article

Amesite Inc. Announces Public Offering

Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in AI-driven solutions, has announced the pricing of its "best efforts" underwritten public offering

1

. The company is set to offer 1,201,667 shares of its common stock at a public offering price of $3.00 per share, aiming to raise approximately $3.6 million before underwriting discounts and commissions

2

.

Key Details of the Offering

  • Pricing: $3.00 per share
  • Total shares: 1,201,667
  • Expected closing date: January 8, 2025
  • Joint book-running managers: Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC

Notably, certain officers and directors of Amesite are participating in the offering with aggregate subscriptions of approximately $1.26 million, demonstrating internal confidence in the company's future

2

.

Intended Use of Proceeds

Amesite plans to utilize the net proceeds from this offering for various purposes, including:

  1. General corporate purposes
  2. Capital expenditures
  3. Working capital
  4. General and administrative expenses

    1

    2

Company Overview and AI Focus

Amesite Inc. is at the forefront of developing and marketing B2C and B2B AI-driven solutions. The company leverages its proprietary AI infrastructure to offer cutting-edge applications catering to both individual and professional needs

1

2

.

One of Amesite's notable products is NurseMagicâ„¢, a mobile app designed for health and care professionals. This AI-powered application streamlines various nursing tasks, including:

  • Creation of nursing notes and documentation
  • Enhancement of patient communication
  • Provision of personalized guidance on patient care, medications, and handling challenging workplace situations

    1

    2

Market Impact and Future Outlook

The public offering comes at a time when AI-driven solutions are gaining significant traction across various industries. Amesite's focus on leveraging AI for both consumer and business applications positions it well in the rapidly evolving tech landscape.

However, as with any forward-looking statements, the company cautions that actual results may differ from projections due to various risks and uncertainties. Amesite's future performance will likely depend on factors such as market adoption of its AI solutions, competitive landscape, and overall economic conditions

1

2

.

Regulatory Compliance

The public offering is being conducted under a shelf registration statement on Form S-3 (Registration No. 333-282999), which was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024

1

2

. Interested investors can access the preliminary prospectus supplement and accompanying prospectus on the SEC's website or obtain copies from Laidlaw & Company (UK) Ltd.

TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo